Blog

We invite you to read our blog. Find out what Quadro® is thinking and doing, and please leave us a comment or question — we’d love to hear from you!
  • Current Good Manufacturing Practice (CGMP) guidelines represent a framework implemented by the United States Food and Drug Administration to ensure that prescription drugs and over-the-counter medications are invariably safe and effective. As such, CGMPs provide important protections for consumers...
  • New drug development is a long, arduous process. From concept to pharmacy shelf, many complicated steps are involved in identifying, developing and incorporating a new active pharmaceutical ingredient (API) into a suitable dosage form. This must then be optimized — and thoroughly tested — for...
  • Particle size is a crucial characteristic of active pharmaceutical ingredients (APIs), and particle size distributions are an important consideration for pharmaceutical manufacturers. Particle size distributions (PSDs) — the range of the individual particle sizes that make up a substance — should...
  • The new drug development/formulation-design process ordinarily involves generating progressively larger batch sizes of investigational product. Amounts produced during the initial laboratory-scale stage are typically 100-1,000 times smaller than the amounts produced during the pilot and final...
  • Numerous industries and applications rely on particle size reduction technology to achieve optimal final product specifications and performance targets. Particle size reduction can be as simple as grinding corn into meal, or as esoteric as harnessing sheer forces to reduce small macro-particles of...